All respondents | LVEF value | ||||||
---|---|---|---|---|---|---|---|
LVEF measured | LVEF not measured | p | Normal (>50%) | Intermediate (40 – 50%) | Reduced (<40%) | p | |
n | 256 | 152 | 167 | 56 | 33 | ||
Time since index MI, years | 2.5 (0.2) | 2.6 (0.2) | <0.001 | 2.5 (0.2) | 2.6 (0.2) | 2.5 (0.2) | 0.046 |
Sex (% women) | 29 | 29 | 1.0 | 29 | 30 | 27 | 1.0 |
Age, years | 64 (12) | 68 (12) | 0.002 | 62 (12) | 68 (11) | 68 (13) | 0.001 |
Education, years, range 7–21 | 10 (3) | 10 (4) | 0.9 | 11 (3) | 10 (3) | 10 (3) | 0.3 |
Smoker at admission | 49a | 39b | 0.07 | 51c | 48d | 45e | 0.8 |
Comorbidities before the index MI | |||||||
Diabetes mellitus | 10 | 6 | 0.3 | 8 | 11 | 15 | 0.5 |
Chronic obstructive pulmonary disease | 8 | 7 | 0.7 | 6 | 13 | 6 | 0.2 |
Hypertension | 29 | 35 | 0.2 | 30 | 29 | 24 | 0.8 |
Previous MI | 17 | 24 | 0.08 | 11 | 24 | 36 | 0.001 |
Angina pectoris | 22 | 30 | 0.08 | 20 | 22 | 33 | 0.2 |
Peripheral vascular disease | 4 | 9 | 0.08 | 2 | 7 | 9 | 0.1 |
Stroke | 5 | 6 | 0.5 | 3 | 7 | 12 | 0.07 |
Heart failure | 2 | 8 | 0.009 | 1 | 2 | 9 | 0.02 |
Index MI, characteristics | |||||||
ST-segment elevation | 59 | 35 | <0.001 | 58 | 70 | 46 | 0.07 |
Localization | 0.1 | <0.001 | |||||
Anterior wall | 44 | 30 | 34 | 57 | 70 | ||
Inferior wall | 41 | 38 | 51 | 27 | 12 | ||
Unknown | 16 | 24 | 15 | 16 | 18 | ||
Q-wave | 48 | 33 | 0.004 | 47 | 48 | 52 | 0.9 |
In-hospital treatment | |||||||
Revascularization | 49 | 22 | <0.001 | 48 | 63 | 33 | 0.02 |
Indication for medication at discharge | |||||||
Secondary prevention | 99 | 98 | 0.7 | 99 | 100 | 97 | 0.4 |
Hypertension | 11 | 12 | 0.8 | 14 | 5 | 6 | 0.1 |
Angina pectoris | 18 | 35 | <0.001 | 19 | 18 | 12 | 0.6 |
Heart failure | 19 | 22 | 0.4 | 7 | 29 | 61 | <0.001 |
Subsequent events | |||||||
New MI | 5 | 7 | 0.5 | 5 | 5 | 3 | 0.8 |
Percutaneous coronary intervention | 15 | 11 | 0.3 | 20 | 5 | 6 | 0.008 |
Coronary artery bypass graft surgery | 11 | 13 | 0.7 | 12 | 7 | 15 | 0.5 |